What the Latest Findings Say About Dexamethasone

A study published in the New England Journal of Medicine reports that among people hospitalized with Covid-19, the use of dexamethasone resulted in lower 28-day risk of death for people who were receiving either invasive mechanical ventilation or oxygen alone at randomization. However, the drug did not show a benefit for people receiving no respiratory support.

The study observed around 2,100 people hospitalized for Covid-19. A portion of the group was randomly assigned to receive 10 days’ worth of dexamethasone combined with their standard care…

--

--

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
Alexandra Sifferlin

Alexandra Sifferlin

Health and science journalist. Former editor of Medium’s Covid-19 Blog and deputy editor at Elemental. TIME Magazine writer before that